Home > Press > OMBU Group Invests in P2i as the Company Raises £12 Million to Accelerate its Growth in Consumer Electronics & Lifestyle Products
Abstract:
Ombu Group has invested £6 million into P2i Ltd, the world leader in liquid repellent nano-coating technology, as part of a £12 million funding round that will support P2i's accelerating commercialization and international growth.
P2i was established in 2004 to commercialize liquid repellent treatments developed by the Ministry of Defence. Its revolutionary technology helps customers protect and improve a wide and growing range of products including sensitive electronic devices, such as mobile phones, MP3 players and hearing aids, which can suffer irreparable damage when exposed to moisture, water and oil. P2i is also active in the Lifestyle, Life Sciences, Filtration & Energy, and Military & Institutional sectors enhancing an assortment of products including footwear such as hiking, running and golf shoes, through to laboratory consumables such as pipette tips. This funding round comes as the company accelerates its growth in the Electronics and Lifestyle markets.
Stephen Brooke, the Chief Executive Officer of Ombu Group, said: "At Ombu, we back fast-growing UK companies with world-class technology that need capital and management support to enable them to scale rapidly and effectively. P2i is a perfect fit for us. It has amazing technology, is experiencing rapid growth and is led by an outstanding management team that we believe has the capacity to turn P2i into a major UK advanced technology business.'
Carl Francis, P2i's Chief Executive, commented: "This substantial new investment is a clear endorsement of our leading position in liquid repellent nano-coating technology. Our business is currently expanding rapidly and is being driven by two core markets, Electronics and Lifestyle through both ‘new customer adoption' and ‘existing customer volume increases'. Across all our markets we are implementing our game changing technology into the productions lines of the world's leading industrial, scientific and consumer brand players. The growth in new customers in the past year has been staggering."
The new money will be invested in four main areas: operational infrastructure and facilities, including further development of the company's Asia operation; marketing and sales capacity; capital equipment; and R&D.
####
About Ombu Group
Ombu Group partners with outstanding business leaders to help them build world-class, advanced technology businesses. Ombu provides capital and management support to fast-growing companies in the fields of industrial technology, energy technology and water technology.
About P2i
P2i is the world leader in liquid repellent nano-coating technology. It was established in 2004 to commercialize liquid-repellent treatments developed by the UK’s Ministry of Defence. Now on a commercial scale, P2i’s patented process has been successfully applied to a wide range of products in a wide range of markets including Lifestyle, Electronics, Life sciences, Military & Institutional and Filtration & Energy.
In consumer sectors, the presence of P2i’s technology is indicated either by ion-mask™, its brand for Lifestyle, footwear and accessories, or Aridion™, its brand for Electronics.
For more information, please click here
Contacts:
Romina Korosy
+44 (0)20 7752 0863
Copyright © Ombu Group
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||